Global Spatial Genomics And Transcriptomics Market 2024-2028
The spatial genomics and transcriptomics market is forecasted to grow by USD 619.21 mn during 2023-2028, accelerating at a CAGR of 11.22% during the forecast period. The report on the spatial genomics and transcriptomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a surge in the adoption of spatial genomics and transcriptomics in drug discovery and development, rising product launches and strategic alliances by vendors, and the emergence of spatial omics as a technology-driven field.
Technavio's spatial genomics and transcriptomics market is segmented as below:
- By Application
- Translation research
- Drug discovery and development
- By Product
- Consumables
- Instruments
- By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing use of spatial omics for biomarker identification as one of the prime reasons driving the spatial genomics and transcriptomics market growth during the next few years. Also, the emerging potential of spatial genomics analysis in cancer diagnostics and advances in sequencing technologies will lead to sizable demand in the market.
The report on the spatial genomics and transcriptomics market covers the following areas:
- Spatial genomics and transcriptomics market sizing
- Spatial genomics and transcriptomics market forecast
- Spatial genomics and transcriptomics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading spatial genomics and transcriptomics market vendors that include 10X Genomics Inc., Akoya Biosciences Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioSpyder Technologies Inc., Cantata Bio LLC, Fulgent Genetics Inc., Illumina Inc., Lunaphore Technologies SA, NanoString Technologies Inc., RareCyte Inc., Rebus Biosystems Inc., Resolve BioSciences GmbH, S2 Genomics Inc., Seven Bridges Genomics Inc., Singular Genomics System Inc., Ultivue Inc., Veranome Biosystems LLC, Vizgen Corp., and PerkinElmer Inc. Also, the spatial genomics and transcriptomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.